MiR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas

Journal of Neuro-Oncology

Volumn 110, Issue 2, 2012, Pages 155-162

  Shi, Lei ^a   Jiang, Dongyi ^b   Sun, Guan ^c   Wan, Yi ^b   Zhang, Shuguang ^a   Zeng, Yanjun ^d   Pan, Tianhong ^a   Wang, Zhimin ^b  

^a JIANGSU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANTONG UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Meningioma; MicroRNA; Rb1

Indexed keywords

MICRORNA; MICRORNA 335; PROTEIN; RETINOBLASTOMA 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MENINGIOMA; MENINX; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LUCIFERASES; MENINGEAL NEOPLASMS; MENINGIOMA; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84867839436     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0951-z     Document Type: Article

References (22)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) World Health Organization classification of tumours of the central nervous system. IARC Press, Lyon
2. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70:2350-2358
3. Wen PY, Yung WKA, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, DeAngelis LM, Mehta M, Tomaso ED, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD (2009) Phase II study of imatinib mesylate for recurrent meningiomas (North American brain tumor consortium study 01-08). Neuro Oncology 11:853-860
4. Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353:1768-1771
5. Saydam O, Shen Y, Würdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing e-cadherin and activating the Wnt/β-catenin signaling pathway. Mol Cell Biol 29:5923-5940
6. Scarola M, Schoeftner S, Schneider C, Benetti R (2010) miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response. Cancer Res 70:6925-6933
7. Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W, Zhou Y, Ou Y, Lin X, Lin Y, Xu D, Zhou Y, Yan G (2011) Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 10:59
8. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L (2011) Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 317(12):1714-1725
9. Tome M, Lopez-Romero P, Albo C, Sepulveda JC, Fernandez-Gutierrez B, Dopazo A, Bernad A, Gonzalez MA (2011) miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 18(6):985-995
10. Darling JL (1990) The in vitro biology of human brain tumors. In: Thomas DGT (ed) Neuro-oncology: primary malignant brain tumors. Johns Hopkins University Press, Baltimore Md, pp 1-25
11. Chang SF, Chang TK, Peng HH, Yeh YT, Lee DY, Yeh CR, Zhou J, Cheng CK, Chang CA, Chiu JJ (2009) BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21CIP1 and p27KIP1 regulation. Mol Endocrinol 23:1827-1838
12. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773
13. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH (1998) Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate 34:145-151
14. Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, Fabris S, Deliliers GL, Neri A (2008) An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics 1:37
15. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ (2010) Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11:50-54
16. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152
17. Classon M, Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917
18. Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, Bulun SE (2008) Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril 89:1771-1776
19. Swiss VA, Casaccia P (2010) Cell-context specific role of the E2F/Rb pathway in development and disease. Glia 58:377-390
20. Du W, Searle JS (2009) The rb pathway and cancer therapeutics. Curr Drug Targets 10:581-589
21. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703-716
22. Knudsen ES, Wang JY (2010) Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16:1094-1099